• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

(S)-2-氨基-3-(3-羟基-5-甲基-4-异恶唑基)丙酸(AMPA)和2S-(2α,3β,4β)-2-羧基-4-(1-甲基乙烯基)-3-吡咯烷乙酸(海人酸)受体的选择性激动剂结合:一项分子模拟研究

Selective agonist binding of (S)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA) and 2S-(2alpha,3beta,4beta)-2-carboxy-4-(1-methylethenyl)-3-pyrrolidineacetic acid (kainate) receptors: a molecular modeling study.

作者信息

Pentikäinen Olli T, Settimo Luca, Keinänen Kari, Johnson Mark S

机构信息

Department of Biochemistry and Pharmacy, Abo Akademi University, Tykistökatu 6A, FIN-20520 Turku, Finland.

出版信息

Biochem Pharmacol. 2003 Dec 15;66(12):2413-25. doi: 10.1016/j.bcp.2003.08.013.

DOI:10.1016/j.bcp.2003.08.013
PMID:14637199
Abstract

Molecular models were constructed, using the published X-ray structure of rat glutamate receptor 2 (GluR2), for the ligand-binding domains of the human (S)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA)- and kainate-selective ionotropic glutamate receptors (iGluRs): GluR1-7 and KA1-2. Based on the analysis of the known X-ray structures of GluR2 in complex with glutamate, kainate, and AMPA, we have constructed binding motifs (relative positioning of a ligand in the binding site and the physico-chemical interactions that take place) for selected agonist ligands and found explanations for ligand-binding selectivity to homomeric receptors among the different iGluRs. Even a single sequence difference can explain significant differences in ligand-binding affinities between two receptors. In total, there are seven residues surrounding the binding cavity that affect agonist selectivity: in GluR2, these residues are Pro478, Thr480, Leu650, Ser654, Thr686, Tyr702, and Met708. Each of these seven positions has been shown, or is predicted, to influence the presence of one or more water molecules that, when present, may form bridging hydrogen bonds between particular ligands and receptors. By using this knowledge it should be possible to design new selective agonist ligands with high affinity for any AMPA/kainate receptor.

摘要

利用已发表的大鼠谷氨酸受体2(GluR2)的X射线结构,构建了人源(S)-2-氨基-3-(3-羟基-5-甲基-4-异恶唑基)丙酸(AMPA)和红藻氨酸盐选择性离子型谷氨酸受体(iGluR):GluR1-7和KA1-2的配体结合域的分子模型。基于对GluR2与谷氨酸、红藻氨酸盐和AMPA复合物的已知X射线结构的分析,我们构建了选定激动剂配体的结合基序(配体在结合位点的相对定位以及发生的物理化学相互作用),并找到了不同iGluR中配体对同聚体受体结合选择性的解释。即使是单个序列差异也能解释两个受体之间配体结合亲和力的显著差异。总共有七个围绕结合腔的残基影响激动剂选择性:在GluR2中,这些残基是Pro478、Thr480、Leu650、Ser654、Thr686、Tyr702和Met708。这七个位置中的每一个都已被证明或被预测会影响一个或多个水分子的存在,当这些水分子存在时,可能会在特定配体和受体之间形成桥连氢键。利用这些知识,应该有可能设计出对任何AMPA/红藻氨酸盐受体具有高亲和力的新型选择性激动剂配体。

相似文献

1
Selective agonist binding of (S)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA) and 2S-(2alpha,3beta,4beta)-2-carboxy-4-(1-methylethenyl)-3-pyrrolidineacetic acid (kainate) receptors: a molecular modeling study.(S)-2-氨基-3-(3-羟基-5-甲基-4-异恶唑基)丙酸(AMPA)和2S-(2α,3β,4β)-2-羧基-4-(1-甲基乙烯基)-3-吡咯烷乙酸(海人酸)受体的选择性激动剂结合:一项分子模拟研究
Biochem Pharmacol. 2003 Dec 15;66(12):2413-25. doi: 10.1016/j.bcp.2003.08.013.
2
Synthesis and in vitro pharmacology at AMPA and kainate preferring glutamate receptors of 4-heteroarylmethylidene glutamate analogues.
Bioorg Med Chem. 2003 Oct 1;11(20):4341-9. doi: 10.1016/s0968-0896(03)00485-1.
3
Stereostructure-activity studies on agonists at the AMPA and kainate subtypes of ionotropic glutamate receptors.离子型谷氨酸受体AMPA和海人酸亚型激动剂的立体结构-活性研究。
Chirality. 2003 Feb;15(2):167-79. doi: 10.1002/chir.10177.
4
Heteroaryl analogues of AMPA. 2. Synthesis, absolute stereochemistry, photochemistry, and structure-activity relationships.AMPA的杂芳基类似物。2. 合成、绝对立体化学、光化学及构效关系
J Med Chem. 1998 Jul 2;41(14):2513-23. doi: 10.1021/jm9801206.
5
Ab initio studies of receptor interactions with AMPA ((S)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl) propionic acid) and kainic acid (2S-(2 alpha, 3 beta, 4 beta))-2-carboxy-4-(1-methylethenyl)-3-pyrrolidineacetic acid.关于受体与AMPA((S)-2-氨基-3-(3-羟基-5-甲基-4-异恶唑基)丙酸)和海人酸((2S-(2α, 3β, 4β))-2-羧基-4-(1-亚乙烯基)-3-吡咯烷乙酸)相互作用的从头算研究
J Mol Model. 2009 Sep;15(9):1109-17. doi: 10.1007/s00894-009-0460-y. Epub 2009 Feb 21.
6
Tetrazolyl isoxazole amino acids as ionotropic glutamate receptor antagonists: synthesis, modelling and molecular pharmacology.作为离子型谷氨酸受体拮抗剂的四唑基异恶唑氨基酸:合成、建模与分子药理学
Bioorg Med Chem. 2005 Sep 15;13(18):5391-8. doi: 10.1016/j.bmc.2005.06.024.
7
(S)-2-Amino-3-(3-hydroxy-7,8-dihydro-6H-cyclohepta[d]isoxazol-4-yl)propionic acid, a potent and selective agonist at the GluR5 subtype of ionotropic glutamate receptors. Synthesis, modeling, and molecular pharmacology.(S)-2-氨基-3-(3-羟基-7,8-二氢-6H-环庚并[d]异恶唑-4-基)丙酸,一种对离子型谷氨酸受体GluR5亚型具有强效和选择性的激动剂。合成、建模及分子药理学。
J Med Chem. 2003 Apr 10;46(8):1350-8. doi: 10.1021/jm0204441.
8
Structural determinants of AMPA agonist activity in analogues of 2-amino-3-(3-carboxy-5-methyl-4-isoxazolyl)propionic acid: synthesis and pharmacology.2-氨基-3-(3-羧基-5-甲基-4-异恶唑基)丙酸类似物中AMPA激动剂活性的结构决定因素:合成与药理学
J Med Chem. 2000 Dec 14;43(25):4910-8. doi: 10.1021/jm0003586.
9
Stereochemistry of glutamate receptor agonist efficacy: engineering a dual-specificity AMPA/kainate receptor.谷氨酸受体激动剂效能的立体化学:构建双特异性AMPA/海人酸受体
Biochemistry. 2004 Dec 21;43(50):15838-44. doi: 10.1021/bi048447y.
10
Low-mode docking search in iGluR homology models implicates three residues in the control of ligand selectivity.
J Mol Recognit. 2005 Mar-Apr;18(2):183-9. doi: 10.1002/jmr.713.

引用本文的文献

1
Glutamate receptor ion channels: structure, regulation, and function.谷氨酸受体离子通道:结构、调节和功能。
Pharmacol Rev. 2010 Sep;62(3):405-96. doi: 10.1124/pr.109.002451.
2
Pharmacological activity of C10-substituted analogs of the high-affinity kainate receptor agonist dysiherbaine.C10 取代高亲和力海人藻酸受体激动剂二氢石蒜碱类似物的药理学活性。
Neuropharmacology. 2010 Mar;58(3):640-9. doi: 10.1016/j.neuropharm.2009.11.013. Epub 2009 Dec 4.
3
Exploring kainate receptor pharmacology using molecular dynamics simulations.利用分子动力学模拟探索 kainate 受体药理学。
Neuropharmacology. 2010 Feb;58(2):515-27. doi: 10.1016/j.neuropharm.2009.08.019. Epub 2009 Sep 6.
4
Ab initio studies of receptor interactions with AMPA ((S)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl) propionic acid) and kainic acid (2S-(2 alpha, 3 beta, 4 beta))-2-carboxy-4-(1-methylethenyl)-3-pyrrolidineacetic acid.关于受体与AMPA((S)-2-氨基-3-(3-羟基-5-甲基-4-异恶唑基)丙酸)和海人酸((2S-(2α, 3β, 4β))-2-羧基-4-(1-亚乙烯基)-3-吡咯烷乙酸)相互作用的从头算研究
J Mol Model. 2009 Sep;15(9):1109-17. doi: 10.1007/s00894-009-0460-y. Epub 2009 Feb 21.
5
Role of the chemical interactions of the agonist in controlling alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor activation.激动剂的化学相互作用在控制α-氨基-3-羟基-5-甲基-4-异恶唑丙酸受体激活中的作用。
Biochemistry. 2007 Feb 6;46(5):1343-9. doi: 10.1021/bi062270l.
6
Crystal structures of the kainate receptor GluR5 ligand binding core dimer with novel GluR5-selective antagonists.含有新型GluR5选择性拮抗剂的红藻氨酸受体GluR5配体结合核心二聚体的晶体结构
J Neurosci. 2006 Mar 15;26(11):2852-61. doi: 10.1523/JNEUROSCI.0123-06.2005.
7
Pharmacological insights obtained from structure-function studies of ionotropic glutamate receptors.从离子型谷氨酸受体的结构-功能研究中获得的药理学见解。
Br J Pharmacol. 2006 Apr;147(8):839-53. doi: 10.1038/sj.bjp.0706689.